Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: didn't JT say ....

A higher share price would benefit a takeover ... they would have use fewer shares for an acquisition

i emphatically disagree ... the best thing about PTSC is an undervalued stock price (at the moment).  Not only that but i also think you are thinking about it all wrong ... i believe we are trying to woo a desired entity not sifting through bargain basement clutter.  if JT has found PTSCs future business it is sure to have other interested parties and it is them who are looking for the right fit and the best rate of return ... business is business.

Share
New Message
Please login to post a reply